We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemoph... Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. Show more
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial results after the market...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 20 Sangamo abstracts for...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the...
Data from novel proprietary neurotropic adeno-associated virus (AAV) delivery capsid, STAC-BBB, demonstrated industry-leading blood-brain barrier (BBB) penetration in non-human primates (NHPs...
Novel AAV capsid engineered by Sangamo showed robust penetration of blood-brain barrier (BBB) and widespread transgene expression throughout brain in non-human primates (NHPs) following...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its fourth quarter and full year 2023 financial results before...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 1.92307692308 | 0.52 | 0.5739 | 0.5 | 926787 | 0.52639385 | CS |
4 | -0.041 | -7.18038528897 | 0.571 | 0.5979 | 0.46001 | 1344898 | 0.52930846 | CS |
12 | -0.01 | -1.85185185185 | 0.54 | 1.48 | 0.46001 | 2411835 | 0.85889098 | CS |
26 | 0.075 | 16.4835164835 | 0.455 | 1.48 | 0.2911 | 2015428 | 0.67531229 | CS |
52 | -0.85 | -61.5942028986 | 1.38 | 1.67 | 0.2911 | 2060577 | 0.85105311 | CS |
156 | -11.35 | -95.5387205387 | 11.88 | 12.8297 | 0.2911 | 1637655 | 3.54247627 | CS |
260 | -10.86 | -95.3467954346 | 11.39 | 19.43 | 0.2911 | 1703010 | 6.49326551 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions